共 27 条
[2]
Metformin Therapy in Diabetes: The Role of Cardioprotection[J] . Saloua Messaoudi,Gerard A. Rongen,Niels P. Riksen.  Current Atherosclerosis Reports . 2013 (4)
[3]
Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control. Wai Bryan,Kearney Leighton G,Hare David L,Ord Michelle,Burrell Louise M,Srivastava Piyush M. Cardiovascular diabetology . 2012
[4]
Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Chun-jun Li,Lin Lv,Hui Li,De-min Yu. Cardiovascular Diabetology . 2012
[5]
Predictors and prevention of diabetic cardiomyopathy[J] . Paras Mishra,Tyagi,Chavali.  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy . 2013 (defa)
[8]
Repaglinide[J] . Lesley J. Scott.  Drugs . 2012 (2)
[9]
Combination Therapy with a Dipeptidyl Peptidase-4Inhibitor,Sulfonylurea,and Metformin Markedly Improves HbA1cLevels in Japanese Patients with Type 2Diabetes Mellitus. Hirao K,Maeda H,Shirabe S,et al. Nippon Rinsho Japanese Journal of Clinical Medicine . 2012
[10]
Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus. Yang ZH,Peng XD. Chinese Medical Journal . 2010